​

10x Genomics Ownership | Who Owns 10x Genomics?

OverviewForecastRevenueFinancialsChartTranscripts

10x Genomics Ownership Summary

10x Genomics is owned by 100.82% institutional investors, 1.60% insiders. Fmr is the largest institutional shareholder, holding 13.74% of TXG shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 4.02% of its assets in 10x Genomics shares.

TXG Ownership Benchmark

TypeName% Inst% Insiders% Retail
Stock10x Genomics100.82%1.60%-2.42%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr17.63M13.74%$675.91M
Vanguard group13.02M10.37%$212.32M
Blackrock funding, inc. /de10.80M8.42%$414.23M
Ark investment management10.00M7.80%$383.52M
Blackrock6.39M5.35%$124.34M
Quantinno capital management lp5.47M4.26%$209.71M
Vanguard capital management5.08M3.96%$194.87M
Price t rowe associates inc /md/4.54M3.54%$174.03M
Sumitomo mitsui trust4.19M3.27%$160.82M
Nikko asset management americas4.19M3.27%$160.74M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Venrock management vi2.11M100.00%$40.98M
Blue water life science advisors, lp642.00K15.50%$24.61M
Freshford capital management600.42K7.88%$23.02M
Sands capital ventures481.77K3.01%$18.47M
Ark investment management10.00M2.49%$383.52M
Exome asset management102.63K2.43%$3.93M
Quantedge capital pte80.95K2.35%$3.10M
Nikko asset management americas4.19M2.07%$160.74M
Casdin capital1.05M2.02%$40.26M
Williamson legacy group95.06K1.81%$3.64M

Top Buyers

HolderShares% AssetsChange
Price t rowe associates inc /md/4.54M0.02%4.38M
Citadel advisors2.78M0.01%2.04M
Point72 asset management1.85M0.08%1.85M
Sixth street partners management company1.09M0.01%1.09M
Anomaly capital management, lp867.79K1.27%867.79K

Top Sellers

HolderShares% AssetsChange
Generation investment management llp---2.88M
Millennium management116.83K0.00%-1.95M
Brown capital management---1.84M
Ark investment management10.00M2.49%-1.71M
Wellington management group llp---1.45M

New Positions

HolderShares% AssetsChangeValue
Point72 asset management1.85M0.08%1.85M$71.04M
Sixth street partners management company1.09M0.01%1.09M$41.68M
Anomaly capital management, lp867.79K1.27%867.79K$33.27M
Samlyn capital504.05K0.31%504.05K$19.33M
Duquesne family office403.10K0.30%403.10K$15.46M

Sold Out

HolderChange
Strategic advocates-2.00
Key financial-2.00
Concourse financial group securities-3.00
Mather group, llc.-4.00
Northwest investment counselors-6.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202639917.70%129,345,4343.31%1001.04%20216.09%13733.01%
Mar 31, 2026170-48.33%47,954,848-61.12%370.39%83-52.30%52-46.39%
Dec 31, 2025225-30.12%77,554,892-36.98%610.62%120-29.82%63-27.59%
Sep 30, 20252961.72%116,328,6192.84%931.13%157-14.21%8320.29%
Jun 30, 20252997.94%122,334,8068.44%981.17%18519.35%73-1.35%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
ARK Disruptive Innovation Full Composite5.11M4.02%-1.90M
ARK Innovation ETF3.89M2.98%-115.09K
Vanguard Total Stock Mkt Idx Inv3.53M2.78%-235.68K
Vanguard Morn Total Stk Mkt Idx Investor3.53M2.78%-235.68K
Vanguard MStar Total Stk Mkt Idx Invest3.54M2.72%11.54K
Vanguard US Total Market Shares ETF3.24M2.65%268.60K
Nikko AM ARK Disruptive Innovation A USD3.14M2.55%126.16K
ARK Genomic Revolution3.11M2.45%61.41K
iShares Russell 2000 ETF3.04M2.39%-53.95K
ARK Genomic Revolution ETF3.09M2.38%-65.19K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 03, 2026STUELPNAGEL JOHN R-Sell$386.53K
Sep 03, 2026STUELPNAGEL JOHN R-Sell$423.21K
Sep 03, 2026STUELPNAGEL JOHN R-Sell$425.33K
Aug 26, 2026Saxonov Serge Chief Executive OfficerSell$220.58K
Aug 26, 2026Saxonov Serge Chief Executive OfficerSell$31.86K

Insider Transactions Trends

DateBuySell
2026 Q3-12
2026 Q2-11
2026 Q1-8
2025 Q4-3
2025 Q3-3

TXG Ownership FAQ

Who Owns 10x Genomics?

10x Genomics shareholders are primarily institutional investors at 100.82%, followed by 1.60% insiders and -2.42% retail investors. The average institutional ownership in 10x Genomics's industry, Biotech Stocks , is 379.61%, which 10x Genomics falls below.

Who owns the most shares of 10x Genomics?

10x Genomics’s largest shareholders are Fmr (17.63M shares, 13.74%), Vanguard group (13.02M shares, 10.37%), and Blackrock funding, inc. /de (10.8M shares, 8.42%). Together, they hold 32.54% of 10x Genomics’s total shares outstanding.

Does Blackrock own 10x Genomics?

Yes, BlackRock owns 5.35% of 10x Genomics, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 124.34M$. In the last quarter, BlackRock increased its holdings by 385.01K shares, a 6.41% change.

Who is 10x Genomics’s biggest shareholder by percentage of total assets invested?

Venrock management vi is 10x Genomics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 2.11M 10x Genomics shares, valued at 40.98M$.

Who is the top mutual fund holder of 10x Genomics shares?

ARK Disruptive Innovation Full Composite is the top mutual fund holder of 10x Genomics shares, with 4.02% of its total shares outstanding invested in 5.11M 10x Genomics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools